Literature DB >> 21302493

[Effect of feiliuping ointment and its disassembled prescriptions on dendritic cell of mice with transplanted Lewis lung cancer].

Hong-gang Zheng1, Bing-kui Piao, Bao-jin Hua.   

Abstract

OBJECTIVE: To explore the possible immuno-regulating mechanism of action of Chinese drugs in different combinations (assembled depending different therapeutic principles) through observing the effects of Feiliuping ointment (FLP) and its disassembled prescriptions on dendritic cells (DC) in blood, spleen and tumor in mice with transplanted Lewis lung cancer (LLC).
METHODS: Percentages of DC in blood, spleen and tumor of mice with transplanted LLC treated by FLP and its disassembled prescriptions were estimated, and the S-100 protein expression in tumor tissue was detected by immunohistochemical method.
RESULTS: The percentage of DC (per thousand) in tumor bearing mice was 0.43 +/- 0.26 in peripheral blood, and 0.32 +/- 0.16 in spleen, significantly lower than those in normal mice 4.68 +/- 0.90 and 3.68 +/- 1.58, P<0.01); and S-100 protein expression in tumor was weakened. After FLP treatment, the percentages of DC (per thousand) in tumor bearing mice were increased to 2.55 +/- 0.29 in peripheral blood and 2.70 +/- 0.63 in spleen (P<0.01), with the S-100 protein expression in tumor tissue up-regulated significantly (P<0.01). Study on different assembled prescriptions of FLP showed that the qi supplementing components of FLP displayed the optimal actions.
CONCLUSION: FLP, a Chinese herbal prescription made depending on Chinese medicine therapeutic principle of strengthening body resistance and consolidating constitution, has an obvious anti-tumor effect, to improve the immunological anti-tumor function of organism by promoting the amount and expression of DC might be the possible intrinsic mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21302493

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  4 in total

1.  Fuzheng Yiliu Granule inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro.

Authors:  Zhi-yun Cao; Xu-zheng Chen; Lian-ming Liao; Jun Peng; Hai-xia Hu; Zhi-zhen Liu; Jian Du
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

Review 2.  Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive Microenvironment.

Authors:  Qiujun Guo; Jie Li; Hongsheng Lin
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

3.  Chinese patent medicine Fei-Liu-Ping ointment as an adjunctive treatment for non-small cell lung cancer: protocol for a systematic review.

Authors:  Honggang Zheng; Shulin He; Rui Liu; Xinyao Xu; Tao Xu; Shuntai Chen; Qiujun Guo; Yebo Gao; Baojin Hua
Journal:  BMJ Open       Date:  2017-01-16       Impact factor: 2.692

4.  Fei-Liu-Ping ointment inhibits lung cancer growth and invasion by suppressing tumor inflammatory microenvironment.

Authors:  Weidong Li; Cihui Chen; Shakir M Saud; Liang Geng; Ge Zhang; Rui Liu; Baojin Hua
Journal:  BMC Complement Altern Med       Date:  2014-05-12       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.